A device hailed as the “world’s first externally identifiable breast implant” has received CE Mark approval, enabling physicians in Europe (and other parts of the world) to immediately ascertain manufacturer name, serial number, lot number, batch number, and other implant-specific datain vivo—by merely scanning the area outside the body with a handheld reader. What can this development tell us about RFID's role in facilitating UDI compliance, preventing counterfeiting, minimizing product recall impact, and more?